The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-((6-methylpyrazin-2-yl)oxy)aniline ID: ALA5275733
Chembl Id: CHEMBL5275733
Max Phase: Preclinical
Molecular Formula: C11H11N3O
Molecular Weight: 201.23
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cncc(Oc2cccc(N)c2)n1
Standard InChI: InChI=1S/C11H11N3O/c1-8-6-13-7-11(14-8)15-10-4-2-3-9(12)5-10/h2-7H,12H2,1H3
Standard InChI Key: ZFDWDKWQAXTCSU-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 201.23Molecular Weight (Monoisotopic): 201.0902AlogP: 2.16#Rotatable Bonds: 2Polar Surface Area: 61.03Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.47CX LogP: 0.94CX LogD: 0.94Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.76Np Likeness Score: -1.17
References 1. Zhao JY, Feng KR, Wang F, Zhang JW, Cheng JF, Lin GQ, Gao D, Tian P.. (2021) A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism., 217 [PMID:33756126 ] [10.1016/j.ejmech.2021.113379 ]